Carbohydrate and Domain Architecture of an Immature Antibody Glycoform Exhibiting Enhanced Effector Functions

Carbohydrate and Domain Architecture of an Immature Antibody Glycoform Exhibiting Enhanced Effector Functions

Max Crispin,Thomas A. Bowden,Charlotte H. Coles,Karl Harlos,A. Radu Aricescu,David J. Harvey,David I. Stuart,E. Yvonne Jones;Max Crispin;Thomas A. Bowden;Charlotte H. Coles;Karl Harlos;A. Radu Aricescu;David J. Harvey;David I. Stuart;E. Yvonne Jones;
Journal of molecular biology 2009 Vol. 387 pp. 1061-1066
174
jones2009journalcarbohydrate

Abstract

Antibodies contain a conserved glycosylation site that has emerged as a target for the modulation of antibody effector functions. The crystal structure of a biosynthetic intermediate of human IgG1, bearing immature oligomannose-type glycans and reported to display increased antibody-dependent cellular cytotoxicity, demonstrates that glycan engineering can bias the Fc to an open conformation primed for receptor binding.

Citation

ID: 270499
Ref Key: jones2009journalcarbohydrate
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
270499
Unique Identifier:
10.1016/j.jmb.2009.02.033
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet